The top ten holdings have a 48. Additionally. 0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 46% YTD Daily Total Return ETF Summary. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. 5. Here, we set out to define in detail the pharmacokinetics of a well-characterized IDR molecule, IDR-1018. 77. Across the 192 current stocks in the fund, all holdings have a weighting between 0. 5x and PE ratio is about 14x. -listed equities in the biotechnology sector. XBI holdings. 38% vs. 2% Top Ten Holdings. 04 per unit, that means that analysts see 73. 01% vs 8. View complete XBI exchange traded fund holdings for better informed ETF trading. Health Care Fund Highlights: 137 Total Holdings $5. With XBI trading at a recent price near $122. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. XLV. Aug 4, 2021 10:47AM EDT. Over a longer time than that, it has no top holdings. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. XBI ETF’s holdings offer significant diversification. 13%) Gold 1,980. 49% weight in the XBI, are bumping into the $164 head resistance and are. 51. $36. ARGX. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. . Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Chart. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. Like IBB, XBI uses diversification to. 2. Immunovant Inc. 66738-1. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. Currency in USD Follow 2W 10W 9M 72. Shares of XBI stock opened at $73. S. 35% vs 0. 2 %. 94 per share, with $121. 3. XBI, whose index recently expanded, also owns only a handful of established biotech companies. LABD. A few losers won't cause XBI to crash. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Toggle navigationNovavax Inc. XBI has traded between $62. 75M), Brown Advisory. The fund’s NAV was $81. Of course the mega caps are less volatile in general for any sector. 94 per share, with $121. Thu, Nov 9, 1:16 PM ET, Market News Video. Below is the comparison between ARKG and XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 88%. XBI: Head-To-Head ETF Comparison. 19%. 98 and standard deviation of 40. 87. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Again, top 10 holdings. Dividend ETFs. 73. It can be found in the fund’s most recent prospectus. S. IBB has a higher 5-year return than XBI (0. 51. 51 on Tuesday. For an investor to take. Export data to Excel for your own analysis. 01M), Whalerock Point Partners LLC ($343. 20 -4. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. Both IBB and XBI are ETFs. XBI Price: 68. The company’s fifty day. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The top holding in XBI receives just a 1. 08 per unit, that means that analysts see 59. XBI's top 10 holdings account for about 11. It is gross of any fee waivers or expense reimbursements. 00. Carnage in small and micro-cap biotech stocks took XBI from $111. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. Holdings. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. 26 during this last 52-week period. Below is the comparison between XBI and XLV. Top 10 Holdings. 67. 47 and a beta of 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. Stock Analysis Chart Headlines Holdings Ownership Ratings. $0. Performance and Risk. The company has an 88. BBC vs XBI. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. 37% in the last one. by Sweta Killa Published on September 18,2023. Holdings; Performance; Risk; Performance Overview-12. 6% of the fund. 50(-0. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). The ETF return is roughly 4. 1005 Broad St 5 Victoria BC V8W 2A1. No company usually makes up more than two percent of. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 15 billion. The fund's investments total to approximately $6. XBI. 65%. ETF Channel Staff - Friday, October 20, 6:48 AM. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Looking at the chart above, XBI's low point in its 52 week range is $62. Its price to cash flow multiples is about 13. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. 97% in the last one year (as of 11/07/2022). XBI has lost 27. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Twin City Holdings Ltd from Port Alberni, BC. Cash and Equivalents. ETF Channel Staff - Friday, October 20, 6:48 AM. 8% of its total assets under management. Both IBB and XBI have a similar number of assets under management. 97. XBI touched $73. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. While this ETF allocates. Holdings. XBI's top 10 holdings account for about 11. *Close price adjusted for splits. N/A. 79 as the 52 week high point — that compares with a last trade of $76. Staples:. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. The beaten-down prices offer a solid buying opportunity for investors. The latter proposal about IBB determines its main difference from XBI - the former is more focused on the large biotech companies (the share of Amgen Inc. In XBI, the top five holdings together represent only 9. 11. 17% for the trailing three-year period, which makes XBI a high. In contrast, most. 50. The gross expense ratio is the fund’s total annual operating expenses ratio. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. As of Oct 31 2023. 15 billion assets under management. Looking at the chart above, XBI's low point in its 52 week range is $63. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. 50 -0. Looking at the chart above, XBI's low point in its 52 week range is $97. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Neena Mishra May 10, 2023. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Both VHT and XBI are ETFs. 7,569,600. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. Top 10 Holdings 16. iShares Biotechnology ETF ETF holdings by MarketWatch. Further, the fund owns $6. VHT has a lower expense ratio than XBI (0. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. S. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). 35%. 78% of XBI's total assets under management. 79 as the 52 week high point — that compares with a last trade of $126. 32% of the total portfolio assets. Themes & Subsectors ETFs. The sale of ETFs is subject to an activity assessment fee (from $0. 78% of XBI's total assets under management. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 2015. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. 0. 70% so far this year and is down about -16. With XBI trading at a recent price near $131. Holdings. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. MTD. 94 per share, with $116. Stock Analysis Chart Headlines Holdings Ownership Ratings. 95. 08%. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. ARKG vs XBI Fund Comparison . Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. As of Oct 31 2023. 2% Category Average. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The weighted harmonic average of closing market price divided by. XBI holdings. With about 135 holdings, it effectively. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. 17. LABU has a higher expense ratio than XBI (1. 15 per share, with $174. Mirati. 1% and 1. Company specialized in: Holding Companies. $0. Complete SPDR S&P Biotech ETF funds overview by Barron's. 96%, and is down about -5. 64 per share, with $174. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Looking at the chart above, XBI's low point in its 52 week range is $100. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. 191), IBB is significantly more concentrated in its top ten holdings than XBI. Real Estate ETFs. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. Seeks to track a modified. Dollar Tree Inc. 04%. Holdings Details. 5% year-to-date and 38. total market composite index. Free ratings, analyses, holdings, benchmarks, quotes, and news. Check out the side-by-side comparison table of XBI vs. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. VHT has a higher 5-year return than XBI (7. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Additionally. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 7% vs -5. Components of. $5. 01%). NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. 0. 26 during this last 52. LABD. Holdings AS OF 04/30/2023. 1% which highlights the scope of the fund and diversification away from company-specific risks. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. VHT vs XBI. 81. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Top Holdings . 79 as the 52 week high point — that compares with a last trade of $133. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Summary. Written by BNK Invest for BNK Invest ->. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. AU. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. XBI Looks. Taking a look at the XBI, it peaked at $174. 26% rating in the component of Value. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. The portfolio of Cathie Wood updated daily. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Fund Analysis. 94 per share, with $174. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. The index and exchange-traded fund ETF are rebalanced four times a year. NAV as of Nov 09, 2023. 66 +2. Written by BNK Invest for BNK Invest ->. $6. Shares of Amgen , IBB's top holding with a weight of 8. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. Looking at the chart above, XBI's low point in its 52 week range is $63. The following charts reflect the allocation of WCLD's underlying. WisdomTree Cloud Computing Fund ETF holdings by MarketWatch. The top 10 holdings account for about 11. 38%. Reserve your copy today. 88%. 66 +2. The top 10 holdings account for about 10. The most heavily invested institutionals were Morgan Stanley ($614. Investo S&P Biotech Sel Industry ETF IE. XBI has a beta of 0. XBI holdings. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . Looking at the chart above, XBI's low point in its 52 week range is $62. 01%). SBIO holds 79 companies vs. Across the 192 current stocks in the fund, all holdings have a weighting between 0. Dividend Yield. Growth of Hypothetical $10,000. This fee is shown as an annual percentage rate (APR). For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. 97. 15 billion. 16bn USD. 8 million shares. 36% of total assets under management. 78% so far this year and in the past one year (as of 11/20/2023), respectively. View Holdings As of 09/30/2023. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc. 22%: Revolution. 0. 42 billion worth of net assets. MRTX. 26% rating in the component of Value. 26%. Historical Price Data. $72. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 37% in the last one. Overview. 78 per share, with $134. S. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 2B. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. Currency in USD. Further, the fund owns $6. S. SPDR S&P Biotech ETF Stock Up 1. View and export this data back to 2006. Looking at the chart above, XBI's low point in its 52 week range is $115. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Name Symbol % Assets. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. $0. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. The ETF has lost about -22. View the latest ETF prices and news for better ETF investing. Start Free Trial. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. com) ReturnsXBI's top 10 holdings account for about 10. XBI has an overall POWR Rating of D, equating to a Sell. 53 (+3. 20. 50% vs. 57 billion. The XBI broke out in Q3 2016 and again in June 2017. Discover historical prices for XBI stock on Yahoo Finance. com. Its top 10 holdings account for approximately 16. 58% and is down about -14. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. XBI has traded between $73. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. 47% vs -5. 13 and $94. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI.